Lung metastases (2023 – CME) – online course
Description
Authors: L. Tselikas
Reviewers: L. Crocetti, M. Das, P. Freyhardt, L. Monfardini and C. Nice
This course corresponds to chapter 2.2.5.3 Non-vascular interventional oncology of the European Curriculum and Syllabus for IR.
Abstract
Lung metastases are common and represent an important turn in the progression of cancer disease. CT scans are the imaging modality of choice for accurate diagnosis, pre-therapeutic work-up and intervention guidance. Since 2000, percutaneous ablation techniques have changed the management of these patients. Although no prospective comparison between radiofrequency ablation and surgery or stereotactic body radiation therapy is available, the high feasibility rate, efficacy and very low morbidity of RFA justifies the growing role of interventional radiology in this indication.
Patient selection, and very importantly tumour size <2-3 cm, is mandatory to achieve the best possible outcome. New technologies, such as microwave ablation and cryotherapy, have recently been developed to overcome the limitations of RFA, and show promising results. So far, irreversible electroporation has lower efficacy rates than the other techniques, although the mechanism of action is very interesting.
This module gives the reader a quick overview of lung metastases with a special focus on percutaneous ablation techniques as a therapeutic option.
Learning objectives
- To understand lung metastasis pathophysiology
- To be able to use the most appropriate imaging technique for diagnosis, pre-treatment work-up, periprocedural guidance and follow-up
- To learn about ablation techniques and their main differences and best indications
- To be able to properly select patients and overcome challenging technical situations (single lung, location near the mediastinum, etc.)
- To become familiar with the results of percutaneous ablation of lung metastases
- To be aware of potential complications and their management
Further information
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapter 2.2.5.3 Non-vascular interventional oncology.
The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1 European CME credit (ECMEC). The CME accreditation for this course will expire on March 31, 2025. A non-CME accredited version of the course will remain available for two more years.
The acquired CME Certificate will be available in the myCIRSE area under CIRSE Academy.
The enrolment period of this course is linked to the validity of the All-Access Pass.
Release date: April 2023
